Article Text
PDF
Statistics from Altmetric.com
The colonisation and assembly of the neonatal microbiota is essential for the development and maturation of the immune system, and the early life from birth to 2 years of age is regarded as a crucial window period. Abnormal microbial colonisation and reduced gut microbiota diversity during this period are linked to the subsequent development of immune-mediated diseases. Dysbiosis of intestinal microbiota in early life can promote dysfunction of the CD4+ T-cell population,1 impacting the development of the child’s immune system and increasing the risk of atopic diseases. Atopic diseases are excessive IgE-mediated immune responses that commonly affect the nose, eyes, skin and lungs. Of these, atopic dermatitis (AD), a chronic and recurring inflammatory skin disease, affects at least 10%–20% of children, often starting in infancy and continuing into adulthood.2
The factors influencing AD are complex. Researchers have conducted meta-analyses of the various factors correlating to the onset of AD in terms of external exposures, individual factors, mechanisms and other diseases, and proposed that factors related to microbiota and infant feeding may play a role in influencing the development of AD, including exclusive breast feeding or formula feeding, duration of breast feeding and timing of food introduction (figure 1 and online supplemental table S1). Some studies have reported that infants exclusively breastfed for more than 3–4 months are less likely to develop AD, especially in the first 4 months of life.3 However, the relationship between breast feeding and AD is controversial. In the Copenhagen longitudinal birth cohort, there was no significant association between the duration of exclusive breast feeding and the development of sensitisation in the first 6 years of life.4 A similar result was also found in Riyadh, where no associations were demonstrable between full or ever breast feeding …
Footnotes
Contributors RZ drafted the initial iteration of the manuscript and figures. JW (0000-0002-5899-8075) conceived and revised the paper. JW is the guarantor.
Funding This work was supported by the National Key Research and Development Program of China (2022YFA1304102), the National Natural Science Foundation of China (32070122, 32370053, T2341010), the Chinese Universities Scientific Fund (2023RC022), Pinduoduo-China Agricultural University Research Fund (PC2023B02015) and the 2115 Talent Development Program of China Agricultural University.
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.